Answer
Yes. Use during pregnancy is permitted based on evidence from earlier Comirnaty vaccines, although direct KP.2 pregnancy data are not yet available.
Sources for this answer
- Comirnaty KP.2 30 microgram/dose dispersion for injection in pre-filled syringe — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.